Matthew Reynolds to Heart Valve Prosthesis Implantation
This is a "connection" page, showing publications Matthew Reynolds has written about Heart Valve Prosthesis Implantation.
Connection Strength
4.353
-
Reynolds MR, Hlatky MA. Replace or Repair? Circ Cardiovasc Qual Outcomes. 2018 11; 11(11):e005093.
Score: 0.500
-
Reynolds MR, Cohen DJ. The cost-effectiveness of transcatheter aortic valve replacement for nonsurgical candidates: revisionist history or the final word? Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):376-8.
Score: 0.346
-
Reynolds MR, Cohen DJ. Reply: To PMID 23122802. J Am Coll Cardiol. 2013 Apr 23; 61(16):1748.
Score: 0.341
-
Reardon MJ, Reynolds MR. Cost-effectiveness of TAVR in the non-surgical population. J Med Econ. 2013; 16(4):575-9.
Score: 0.336
-
Reynolds MR, Cohen DJ. Reply: To PMID 22818074. J Am Coll Cardiol. 2013 Jan 08; 61(1):108-9.
Score: 0.334
-
Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012 Dec 25; 60(25):2683-92.
Score: 0.330
-
Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, Rihal CS, Brown DL, Smith CR, Leon MB, Cohen DJ. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol. 2012 Aug 07; 60(6):548-58.
Score: 0.323
-
Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012 Mar 06; 125(9):1102-9.
Score: 0.313
-
Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, Herrmann HC, Kapadia S, Kodali SK, Makkar RR, Pichard AD, Cohen DJ. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011 Nov 01; 124(18):1964-72.
Score: 0.306
-
Barker CM, Reynolds MR, Reardon MJ, Van Houten JL, Murphy SME, Mollenkopf SA, Feldman TE. Relation of Institutional Mitral Valve Surgical Volume to Surgical and Transcatheter Outcomes in Medicare Patients. Am J Cardiol. 2021 05 15; 147:94-100.
Score: 0.147
-
Barker CM, Reardon MJ, Reynolds MR, Feldman TE. Association Between Institutional Mitral Valve Procedure Volume and Mitral Valve Repair Outcomes in Medicare Patients. JACC Cardiovasc Interv. 2020 05 11; 13(9):1137-1139.
Score: 0.137
-
Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, Shen C, Choi E, Yeh RW. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. Eur Heart J. 2019 07 14; 40(27):2231-2239.
Score: 0.131
-
Baron SJ, Wang K, House JA, Magnuson EA, Reynolds MR, Makkar R, Herrmann HC, Kodali S, Thourani VH, Kapadia S, Svensson L, Mack MJ, Brown DL, Russo MJ, Smith CR, Webb J, Miller C, Leon MB, Cohen DJ. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Circulation. 2019 02 12; 139(7):877-888.
Score: 0.127
-
Arnold SV, Li Z, Vemulapalli S, Baron SJ, Mack MJ, Kosinski AS, Reynolds MR, Hermiller JB, Rumsfeld JS, Cohen DJ. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry. JAMA Cardiol. 2018 12 01; 3(12):1151-1159.
Score: 0.126
-
Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. JACC Cardiovasc Interv. 2015 Aug 17; 8(9):1207-1217.
Score: 0.100
-
Arnold SV, Lei Y, Reynolds MR, Magnuson EA, Suri RM, Tuzcu EM, Petersen JL, Douglas PS, Svensson LG, Gada H, Thourani VH, Kodali SK, Mack MJ, Leon MB, Cohen DJ. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv. 2014 Dec; 7(6):829-36.
Score: 0.095
-
Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, Zajarias A, Thourani VH, Green P, Rod?s-Cabau J, Beohar N, Mack MJ, Leon MB, Cohen DJ. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation. 2014 Jun 24; 129(25):2682-90.
Score: 0.092
-
Gadey G, Reynolds MR. Cost-effectiveness considerations in transcatheter management of valvular heart disease. Can J Cardiol. 2014 Sep; 30(9):1058-63.
Score: 0.091
-
Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol. 2014 Jul 15; 64(2):182-92.
Score: 0.088
-
Osnabrugge RL, Kappetein AP, Reynolds MR, Cohen DJ. Cost-effectiveness of transcatheter valvular interventions: economic challenges. EuroIntervention. 2013 Sep 10; 9 Suppl:S48-54.
Score: 0.088